2.2 Peripheral Artery Disease and Microvascular Dysfunction in Diabetes

Peripheral Artery Disease and Microvascular Dysfunction in Diabetes

Impaired lower-extremity perfusion is a primary determinant of wound healing failure and lower-extremity amputation in patients with diabetes. Vascular disease in diabetes is multifaceted, involving macrovascular peripheral artery disease (PAD), medial arterial calcification (Mönckeberg's sclerosis), and microvascular regulatory dysfunction. A rigorous understanding of how diabetic vascular pathology differs from non-diabetic atherosclerosis is vital for accurate diagnostic interpretation, offloading planning, and timely vascular surgery referral.

---

1. Macrovascular Disease: Distinct Diabetic PAD Distribution

Peripheral artery disease (PAD) is present in up to 50% of all patients presenting with a diabetic foot ulcer. While non-diabetic atherosclerosis typically affects large, proximal conduits—such as the aortoiliac system, common femoral artery, and superficial femoral artery—diabetic macrovascular disease exhibits a unique anatomical and morphological phenotype.

                    MACROVASCULAR DISTRIBUTION COMPARISON

          Non-Diabetic Atherosclerosis           Diabetic Atherosclerosis
                 ┌───────────────┐                  ┌───────────────┐
                 │   Aortoiliac  │ (Frequent)       │   Aortoiliac  │ (Less Common)
                 └───────┬───────┘                  └───────┬───────┘
                         ▼                                  ▼
                 ┌───────────────┐                  ┌───────────────┐
                 │   Fem-Pop     │ (Predominant)    │    Fem-Pop    │ (Variable)
                 └───────┬───────┘                  └───────┬───────┘
                         ▼                                  ▼
                 ┌───────────────┐                  ┌───────────────┐
                 │ Infrapopliteal│ (Infrequent)     │ Infrapopliteal│ (PREDOMINANT: Tibial,
                 └───────────────┘                  └───────┬───────┘  Peroneal Tandem Lesions)
                                                            ▼
                                                    ┌───────────────┐
                                                    │  Pedal Arch   │ (Frequently Spared
                                                    └───────────────┘  Collateral Target)

Infrapopliteal (Below-the-Knee) Predilection

In patients with diabetes, atherosclerotic occlusive disease characteristically skips or minimally involves the proximal aortoiliac segment, preferentially targeting the infrapopliteal, below-the-knee (BTK) trifurcation vessels:

1. Anterior tibial artery (continuing as the dorsalis pedis artery).
2. Posterior tibial artery (dividing into medial and lateral plantar arteries).
3. Peroneal artery (providing critical collateral perforating branches to the anterior and posterior systems).

Lesion Morphology: Diffuse, Tandem, Multi-Segmental

Rather than discrete, focal plaques, diabetic tibial disease is characterized by long, diffuse, multi-segmental, tandem stenoses and total occlusions. Multiple consecutive arterial segments are narrowed or obliterated over lengths of 10 to 20 cm or more. Sclerotic calcification frequently encases the entire vessel circumference.

Sparing of the Pedal Arch and Digital Vessels

Despite extensive, multisegmental tibial artery occlusion, the distal foot vessels—specifically the dorsalis pedis artery, the deep plantar arch, and occasionally the plantar digital arteries—are often relatively spared or reconstituted by collateral flow from peroneal perforators. This anatomical sparing is clinically critical: it provides a patent target bed for distal surgical bypass grafting (e.g., femoral-to-dorsalis pedis bypass) or retrograde endovascular recanalization, enabling successful limb salvage in limbs that would otherwise face major amputation.

Atypical and Masked Clinical Presentations

In non-diabetic individuals, the hallmark symptom of PAD is intermittent claudication—exercise-induced calf cramping relieved by 2 to 5 minutes of rest. In diabetic patients, concomitant distal symmetric sensory neuropathy abolishes ischemic nociception. Consequently, patients rarely experience claudication. Instead, diabetic PAD typically remains entirely asymptomatic until it presents acutely as chronic limb-threatening ischemia (CLTI), rest pain masked as neuropathic numbness, an ischemic digital gangrene, or a non-healing neuroischemic ulceration that fails to progress after minor mechanical trauma.

---

2. Medial Arterial Calcification (Mönckeberg's Arteriosclerosis)

Mönckeberg's arteriosclerosis, also termed medial arterial calcification (MAC) or medial calcinosis, is a non-atheromatous degenerative condition characterized by calcium phosphate (hydroxyapatite) deposition within the tunica media of medium and small muscular arteries.

                  VESSEL WALL PATHOLOGY: ATHEROMA VS. MÖNCKEBERG

       Atherosclerosis (Intimal)           Mönckeberg's Sclerosis (Medial)
     ┌────────────────────────────┐         ┌────────────────────────────┐
     │  Adventitia                │         │  Adventitia                │
     │  Media                     │         │  CALCIFIED MEDIA (Rigid)   │
     │  ATHEROMA IN INTIMA        │         │  Intima (Normal / Smooth)  │
     │  LUMINAL STENOSIS / PLUG   │         │  PATENT LUMEN (Rigid Pipe) │
     └────────────────────────────┘         └────────────────────────────┘
      • Direct flow reduction               • Wall noncompressibility
      • True ischemia                       • ABI Falsely Elevated (> 1.30/1.40)
      • Thromboembolic risk                 • TBI & Doppler Waveforms Required

Cellular Pathophysiology: Osteogenic Phenotype Transdifferentiation

Medial arterial calcification is not simply a passive, degenerative mineral precipitation; it is an active, regulated, cell-mediated biological process:

• Chronic hyperglycemia, hyperphosphatemia, advanced glycation end-products, and oxidative stress induce vascular smooth muscle cells (VSMCs) within the tunica media to downregulate smooth muscle contractile markers (such as alpha-smooth muscle actin).
• The VSMCs undergo transdifferentiation into an osteoblast-like phenotype, expressing bone-specific transcription factors (Runx2, osterix) and secreting bone matrix proteins (osteocalcin, alkaline phosphatase).
• Sympathetic autonomic denervation contributes directly to this process: loss of vascular sympathetic tone disrupts local trophic signaling and alters vessel wall mineral metabolism, dramatically accelerating medial hydroxyapatite crystal formation.

Hemodynamic Impact: The "Lead Pipe" Vessel

Unlike intimal atherosclerosis, pure Mönckeberg's sclerosis does not protrude into the arterial lumen. The vascular endothelial lining remains smooth, and the lumen itself is not stenosed or occluded by the medial calcium deposits. However, the concentric calcification transforms pliable, elastic arteries into rigid, non-compliant, non-distensible "lead pipes":

• The loss of arterial compliance abolishes the Windkessel effect (the elastic recoil of arteries that dampens systolic pressure spikes and sustains diastolic forward flow).
• Reflected arterial pressure waves return prematurely to the heart during systole, producing isolated systolic hypertension, widened pulse pressure, and severe end-organ microvascular shear stress.

Diagnostic Pitfall: The Falsely Elevated Ankle-Brachial Index (ABI)

The clinical significance of Mönckeberg's sclerosis lies in its profound disruption of noninvasive arterial diagnostics. During a standard Ankle-Brachial Index (ABI) assessment, a pneumatic blood pressure cuff is placed above the malleoli and inflated until arterial flow stops, as detected by a continuous-wave Doppler probe.

• When the tunica media is heavily calcified, the arterial wall resists external compression.
• Suprasystolic cuff pressures exceeding 250 to 300 mmHg are required to overcome the physical rigidity of the calcified wall, or the vessel may remain entirely incompressible.
• This yields falsely elevated ABI values (> 1.30 or > 1.40), or an explicit designation of "vessels noncompressible."

Clinical Exam Trap: The ABI of 1.45 Myth

A common clinical and examination error is interpreting an ABI of 1.40 to 1.50 as "exceptional, supernormal arterial perfusion." In reality, an ABI > 1.30 or > 1.40 is completely non-diagnostic and invalid. Heavy medial calcification frequently coexists with severe, tandem atherosclerotic intimal occlusions of the tibial arteries. An insensate patient with an ABI of 1.45 may have profound distal ischemia and be days away from limb-threatening tissue gangrene.

Alternative Noninvasive Vascular Modalities

Whenever an ABI is > 1.30, > 1.40, or noncompressible, clinicians must abandon the ankle pressure and immediately employ alternative diagnostic modalities:

1. Toe-Brachial Index (TBI): Digital arteries in the toes have minimal or no tunica media and are rarely affected by Mönckeberg's medial calcification. A miniature pneumatic cuff placed on the proximal hallux or second toe, coupled with a photoplethysmography (PPG) sensor, yields reliable systolic pressures.
   • Normal TBI: ≥ 0.70.
   • Impaired Perfusion: TBI < 0.70.
   • Severe Ischemia / CLTI: Absolute toe systolic pressure < 30 mmHg (or TBI < 0.25). Wounds with toe pressure < 30 mmHg have virtually zero probability of spontaneous healing without revascularization.
2. Continuous-Wave (CW) Doppler Waveform Analysis: Qualitative acoustic and visual waveform interrogation of the dorsalis pedis and posterior tibial arteries:
   • Triphasic (Normal): Rapid systolic upstroke, sharp peak, early diastolic flow reversal, and late diastolic forward recovery.
   • Biphasic (Mild-to-Moderate Stenosis): Rapid upstroke, loss of diastolic flow reversal, and blunted forward diastolic flow.
   • Monophasic (Severe Occlusion / Blunted Flow): Slow, broad systolic upstroke, rounded peak, and prolonged, low-velocity continuous forward flow throughout diastole.
3. Transcutaneous Oxygen Pressure (TcPO2): Evaluates local microvascular oxygen diffusion across the heated skin:
   • Normal Perfusion: > 50 mmHg.
   • Marginal Healing Potential: 30–40 mmHg.
   • Critical Limb Ischemia / Failure to Heal: < 30 mmHg (absolute indication for vascular surgery referral).

---

3. Microvascular Dysfunction: Dispelling the Occlusive Myth

For decades, medical literature perpetuated the erroneous dogma that diabetes causes a specific "small vessel occlusive disease" (microvascular occlusion), alleging that microscopic arterioles and capillaries throughout the diabetic foot become physically plugged with thrombi or endothelial proliferation, rendering surgical revascularization futile.

Dismantling the Myth: The Work of LoGerfo

Pioneering histological and hemodynamic studies led by Dr. Frank LoGerfo in the 1980s and 1990s conclusively demolished this concept. Extensive histopathological biopsies of diabetic foot skin and amputated specimens demonstrated that cutaneous capillaries, metarterioles, and precapillary arterioles remain physically patent. There is no widespread, mechanical occlusive lesion obstructing capillary lumens in the diabetic foot. Macrovascular bypass grafting down to the dorsalis pedis or plantar arteries restores robust distal perfusion and heals ulcers, proving that the microcirculatory conduit remains open.

True Microangiopathy: Functional and Regulatory Failure

While the diabetic microvasculature is physically patent, it suffers from severe functional, regulatory, and biochemical dysregulation:

                      TRUE DIABETIC MICROANGIOPATHY

     Physical Lumen:                     PATENT (No physical occlusive plug)
                                          │
     Biochemical & Structural Pathology:  ├─► Endothelial Dysfunction (eNOS uncoupling, NO ↓)
                                          ├─► Capillary Basement Membrane Thickening
                                          ├─► Loss of Neurogenic Hyperemia (CGRP/SP ↓)
                                          └─► Impaired Leukocyte Diapedesis
                                          │
     Functional Consequence:             BLUNTED INFLAMMATORY SURGE & LOCAL HYPOXIA

Endothelial Dysfunction and Nitric Oxide Deficit

The healthy vascular endothelium synthesizes nitric oxide (NO) via endothelial nitric oxide synthase (eNOS), maintaining basal vasodilation, inhibiting platelet aggregation, and suppressing leukocyte adhesion. In diabetes:

• Intracellular hyperglycemia and reactive oxygen species uncouple eNOS from its essential cofactor, tetrahydrobiopterin (BH4). Instead of producing NO, uncoupled eNOS generates additional superoxide radicals.
• Advanced glycation end-products scavenge and quench remaining bioavailable NO.
• Concurrently, production of endothelin-1 and vasoconstrictor prostanoids (thromboxane A2) surges.
• The microvascular bed loses its fundamental capacity for endothelium-dependent vasodilation.

Capillary Basement Membrane Thickening

Hyperglycemia stimulates excessive synthesis and reduced degradation of extracellular matrix components, predominantly type IV collagen, laminin, and fibronectin, within the basal lamina of cutaneous capillaries. The capillary basement membrane becomes markedly thickened and stratified.

• Although this thickening does not occlude the capillary lumen, it significantly increases the physical diffusion distance for molecular oxygen, nutrients, and waste products between erythrocytes and perivascular fibroblasts.
• It stiffens the capillary wall, impairing capillary compliance and reducing red blood cell deformability during microcirculatory transit.

Blunted Neurogenic Hyperemia and the Axon Reflex

Under normal physiological conditions, local mechanical trauma, mild heat, or chemical irritation stimulates unmyelinated sensory C-fibers, triggering the axon reflex ("triple response of Lewis"). Sensory nerve endings release potent vasodilatory neuropeptides, specifically substance P and calcitonin gene-related peptide (CGRP). This initiates immediate, vigorous, localized precapillary vasodilation and a robust hyperemic surge, flooding the injured tissue with blood, oxygen, and inflammatory cells.

• In diabetic neuropathy, degeneration of sensory C-fibers eliminates neuropeptide release.
• Even when sensory axons fire, the underlying endothelial cells cannot respond with NO-mediated vasodilation.
• Consequently, the neurogenic hyperemic response is severely blunted or completely absent. When an insensate foot sustains mechanical or thermal injury, the expected protective surge of arterial blood does not occur, leaving the traumatized zone relatively ischemic.

Impaired Leukocyte Delivery and Cellular Defense

The convergence of endothelial dysfunction, thickened basement membranes, and absent hyperemic reserve severely impairs host defense at the wound interface. Under normal conditions, leukocytes roll along endothelial selectins, firmly adhere via integrins, and undergo diapedesis (transendothelial migration) into the injured matrix to engulf invading pathogens. In the diabetic foot:

• Blunted microvascular flow limits the delivery of circulating neutrophils and monocytes to the wound edge.
• Thickened perivascular basement membranes impede efficient leukocyte extravasation into the wound bed.
• Delivered neutrophils display impaired chemotaxis, blunted phagocytosis, and defective respiratory burst bactericidal killing.
• Minor superficial abrasions or subkeratotic hematomas that would resolve uneventfully in a healthy individual quickly deteriorate into limb-threatening polymicrobial infections.

---

4. Summary: Vascular Pathology in the Diabetic Foot